Back to trial

NCT01275677

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer

Version 818 to 819 · National Cancer Institute (NCI)

Patch inspector

Version 818 to 819

2 operations 2 path groups ctgov_internal_history
ClinicalTrials.gov
Severity is deterministic uncalibrated triage metadata, not validated review priority. Operation-level severity is inferred from deterministic path rules. Rule matches shown per operation are approximate previews (they skip the pipeline's suppression passes); the authoritative classification is the stored event record.
Plain-language summary

Manual review pending.

Rules fired
arms_or_interventions_change
Value signals

None recorded.

Provenance
Source
ctgov_internal_history
Fetched
2026-06-18 19:09:13+00
Raw hash
2b13e825c6b6f5c2eb148edb7eafbecafce0c7f6e39003302fd5b89e2c6fb326
Payload
Source URL
Design Trial model, phase, allocation, masking, arms, or interventions. Triage: High 1 ops
replace /protocolSection/armsInterventionsModule/interventions/2/otherNames/4
Triage: High
Arm Intervention Change Operation 2
Matched rules
  • arms_or_interventions_change Arms or interventions changes can alter treatment/comparator structure.
Before
Adriamycin Hydrochloride
After
Adriamycin hydrochloride
Other registry fields Changes outside the current high-signal rule families. Triage: Uncategorized 1 ops
replace /protocolSection/statusModule/lastUpdateSubmitDate
Triage: Uncategorized
Uncategorized Operation 1
Before
2017-07-07
After
2017-07-10
Raw JSON Patch 
[
  {
    "op": "replace",
    "path": "/protocolSection/statusModule/lastUpdateSubmitDate",
    "value": "2017-07-10"
  },
  {
    "op": "replace",
    "path": "/protocolSection/armsInterventionsModule/interventions/2/otherNames/4",
    "value": "Adriamycin hydrochloride"
  }
]